Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway | Cell Death Discovery
Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation - Wang - 2020 - Cancer Medicine - Wiley Online Library
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Sitagliptin - Wikipedia
Sitagliptin (Januvia) and Saxagliptin (Onglyza) (DPP-4 Inhibitors) for Nursing RN
Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus. - Abstract - Europe PMC
Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action
IJMS | Free Full-Text | Novel Potentials of the DPP-4 Inhibitor Sitagliptin against Ischemia-Reperfusion (I/R) Injury in Rat Ex-Vivo Heart Model | HTML
Frontiers | Clinical Use of DPP-4 Inhibitors | Endocrinology
Mechanism of action for GIP, GLP-1 analogues and DPP4 inhibitors in... | Download Scientific Diagram
Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea | SpringerLink
Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome: Trends in Endocrinology & Metabolism
Do we know the true mechanism of action of the DPP‐4 inhibitors? - Andersen - 2018 - Diabetes, Obesity and Metabolism - Wiley Online Library
Involvement of brain natriuretic peptide signaling pathway in the cardioprotective action of sitagliptin - ScienceDirect